Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
33.43
-0.85 (-2.48%)
Apr 19, 2024, 4:30 PM EDT - Market closed

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $994.68 million. The enterprise value is $907.41 million.

Market Cap 994.68M
Enterprise Value 907.41M

Important Dates

The next estimated earnings date is Saturday, May 11, 2024, before market open.

Earnings Date May 11, 2024
Ex-Dividend Date n/a

Share Statistics

Belite Bio has 29.75 million shares outstanding.

Shares Outstanding 29.75M
Owned by Insiders (%) 60.29%
Owned by Institutions (%) 0.81%
Float 11.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 11.00
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 24.76, with a Debt / Equity ratio of 0.01.

Current Ratio 24.76
Quick Ratio 24.50
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,263.92

Financial Efficiency

Return on equity (ROE) is -48.00% and return on invested capital (ROIC) is -34.68%.

Return on Equity (ROE) -48.00%
Return on Assets (ROA) -45.50%
Return on Capital (ROIC) -34.68%
Revenue Per Employee n/a
Profits Per Employee -$1.58M
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Belite Bio has paid $9,000 in taxes.

Income Tax 9,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +12.14% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +12.14%
50-Day Moving Average 42.55
200-Day Moving Average 36.33
Relative Strength Index (RSI) 32.85
Average Volume (30 Days) 54,014

Short Selling Information

Short Interest 39,121
Short Previous Month 59,470
Short % of Shares Out 0.33%
Short % of Float n/a
Short Ratio (days to cover) 0.76

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -31.67M
Pretax Income -31.62M
Net Income -31.63M
EBITDA -31.20M
EBIT -31.60M
Earnings Per Share (EPS) -$1.19
Full Income Statement

Balance Sheet

The company has $88.16 million in cash and $886,000 in debt, giving a net cash position of $87.27 million or $2.93 per share.

Cash & Cash Equivalents 88.16M
Total Debt 886,000
Net Cash 87.27M
Net Cash Per Share $2.93
Equity / Book Value 90.43M
Book Value Per Share 3.04
Working Capital 86.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.84 million and capital expenditures -$63,000, giving a free cash flow of -$29.90 million.

Operating Cash Flow -29.84M
Capital Expenditures -63,000
Free Cash Flow -29.90M
FCF Per Share -$1.12
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -33.12%
Shareholder Yield -33.12%
Earnings Yield -3.18%
FCF Yield -3.01%

Analyst Forecast

The average price target for Belite Bio is $48.80, which is 45.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target $48.80
Price Target Difference 45.98%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1